Skip to main content
T&R Biofab Co., Ltd logo

T&R Biofab Co., Ltd — Investor Relations & Filings

Ticker · 246710 ISIN · KR7246710008 KO Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2026-06-08 Director's Dealing
Country KR South Korea
Listing KO 246710

About T&R Biofab Co., Ltd

http://www.tnrbiofab.com/en/

T&R Biofab Co., Ltd. is a biomedical engineering company specializing in the development and commercialization of regenerative medical technologies. The company utilizes its proprietary 3D bioprinting technology to manufacture a range of products. Its primary offerings include 3D-printed, bioresorbable medical scaffolds designed to aid in the regeneration and reconstruction of tissues and organs. Other key business areas encompass bio-surgical solutions, the development of organoids and mini-tissues for research and therapeutic applications, and the use of human induced pluripotent stem cells (hiPSC).

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 91% confidence The document is a regulatory insider report detailing a director’s personal shareholdings and transactions (임원·주요주주 특정증권등 소유상황보고서) filed with the Securities and Futures Commission and Korea Exchange, matching the definition of ‘Director’s Dealing’ (reports of personal share transactions by company directors and executives).
2026-06-08 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 96% confidence The document is titled “분기보고서” (Quarterly Report) for the 14th period, covering 2026-01-01 to 2026-03-31, and contains comprehensive financial tables, business overview, capital changes, and detailed narrative sections typical of an interim/quarterly report filed with regulatory authorities. It is clearly the report itself (not an announcement or summary) and includes actual financial and operational data for the quarter. Therefore, it is classified as an Interim/Quarterly Report. Q1 2026
2026-05-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is the Korean “임원ㆍ주요주주 특정증권등 소유상황보고서” (Executive & Major Shareholder Specific Securities Ownership Report), detailing shareholdings, conversions, and transactions by an executive. This matches an insider transaction disclosure by directors/executives, which falls under Director’s Dealing (DIRS).
2026-04-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 92% confidence The document is a Korean regulatory disclosure titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” which details an executive’s (정승교) personal shareholdings and changes in those holdings, including conversions and dispositions. This matches the definition of insider trades by company directors/executives, fitting the “Director's Dealing” category.
2026-04-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is an insider shareholding report (“임원ㆍ주요주주 특정증권등 소유상황보고서”) detailing an executive’s (임원) holdings, transactions, and changes in share counts and ratios. It is a regulator-mandated insider transaction filing by a director. This clearly matches the ‘Director’s Dealing’ category.
2026-04-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 92% confidence The document is a statutory report filed by an executive (임원) and major shareholder detailing their holdings and changes in ownership of securities (specific securities, number of shares, percentages, acquisition/disposal dates, and transaction details). This matches the "Director's Dealing" category – reporting personal share transactions by company directors and executives. Thus the correct category is DIRS.
2026-04-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.